# Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis

> **NCT01226147** · PHASE2 · UNKNOWN · sponsor: **Kinki University** · enrollment: 20 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Tamibarotene

## Key facts

- **NCT ID:** NCT01226147
- **Lead sponsor:** Kinki University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01226147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01226147, "Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01226147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*